Melt-formulated, multi-particulate oral dosage form

Details Melt-formulated, multi-particulate oral dosage form Melt-formulated, multi-particulate oral dosage form

2006-03-03

2010-02-23

Padmanabhan, Sreeni (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C424S046000, C424S450000, C514S192000

Reexamination Certificate

active

07666860

ABSTRACT:
A melt-formulated, multiparticulate, oral dosage form containing clavulanic acid and/or at least one physiologically acceptable salt thereof and at least one sucrose fatty acid ester and optionally further physiologically acceptable auxiliary substances; a process for producing such a dosage form, combination dosage forms with β-lactam antibiotics, and the pharmaceutical use thereof, e.g., for treating bacterial infections.

REFERENCES:
patent: 6051255 (2000-04-01), Conley et al.
patent: 6783773 (2004-08-01), Storm et al.
patent: 2002/0015730 (2002-02-01), Hoffmann et al.
patent: 2003/0017208 (2003-01-01), Ignatious et al.
patent: S56-75437 (1981-06-01), None
patent: 05219885 (1993-08-01), None
patent: WO 95/20946 (1995-08-01), None
patent: WO 95/28927 (1995-11-01), None
patent: WO 00/45888 (2000-08-01), None
patent: WO 01/66081 (2001-09-01), None
International Search Report dated Aug. 6, 2005 (Three (3) pages).
German Search Report dated Jun. 3, 2004 (Two (2) pages).

Affiliated with

Also associated with

Rating

Melt-formulated, multi-particulate oral dosage form does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Melt-formulated, multi-particulate oral dosage form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melt-formulated, multi-particulate oral dosage form will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4224484